Our deep expertise in oncology and artificial intelligence empowers us to analyze vast multimodal datasets with advanced AI algorithms. This capability enables us to uncover novel therapeutic targets, identify lead compounds, elucidate mechanisms of action, and explore synergistic drug combinations. Our platform also drives the development of next-generation antibody-drug conjugates (ADCs), advancing the precision and effectiveness of cancer treatment.